title: Generic biopharmaceutical drugs: an economic and policy analysis.
abstract: Encouraging both generic drug competition and pharmaceutical innovation is difficult, especially in the case of follow-on biologics. Can the U.S. nurture a system that seeks both lower drug prices now and new and improved medications in the future?
authors: Erwin A
authors: EA
authors: Blackstone
authors: Joseph P
authors: JP
authors: Fuhr
references: Wall St J (East Ed). 2005 Nov 16;:A15
references: 16502533
references: Nat Biotechnol. 2004 Nov;22(11):1343-6
references: 15529145
references: Manag Care. 2003 Sep;12(9):50-1
references: 14528675
references: Drug Discov Today. 2004 Oct 1;9(19):817-20
references: 15381127
references: Health Aff (Millwood). 2006 Mar-Apr;25(2):w61-73
references: 16495287
references: Drug Discov Today. 2005 Apr 15;10(8):533-5
references: 15837591
references: Food Drug Law J. 2002;57(2):247-71
references: 12436990